Immunotherapy in hepatocellular carcinoma: Primed to make a difference?
/in Dendritic Cells, Hepatocellular Carcinoma, International Publications /von 2015-11-05 / Cancer 2016 Feb;122(3):367-77Reirradiation and hyperthermia for irresectable locoregional recurrent breast cancer in previously irradiated area: Size matters
/in Breast Cancer, Hyperthermia, International Publications /von 2015-11-02 / Radiother Oncol 2015 Nov;117(2):223-8Hyperthermia: an effective strategy to induce apoptosis in cancer cells
/in Hyperthermia, International Publications /von 2015-11-01 / Apoptosis 2015 Nov;20(11):1411-9
IMMUN-ONKOLOGISCHES ZENTRUM KÖLN
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Das IOZK
Die IOZK Immuntherapie
Aktuelles und Int. Publikationen
- Recent developments in targeting breast cancer stem cells (BCSCs): a descriptive review of therapeutic strategies and emerging therapies
- Neoantigen-targeted dendritic cell vaccination in lung cancer patients induces long-lived T cells exhibiting the full differentiation spectrum
- Individualized Multimodal Immunotherapy (IMI): Scientific Rationale and Clinical Experience from a Single Institution